Therma Bright Signs IR Agreement with Barwicki Investor Relations, Adds $300,000 to Treasury Through Exercise of Warrants and Options; and Grants Options

Toronto, Ontario–(Newsfile Corp. – December 24, 2020) – Therma Bright Inc. (TSXV: THRM) (“Therma” or the “Company”), a progressive medical device technology company, announces that it has engaged Barwicki Investor Relations to provide investor relations services to the Company. Founded by Andrew Barwicki in 2006, Barwicki Investor Relations is a full service investor relations firm representing publicly traded companies and pre-IPO companies. Andrew Barwicki has 25+ years experience in finance, investor relations, investment banking and marketing. Mr. Barwicki worked in numerous industries and represented public companies in various sectors, including consumer products, regional and national banks, gold, silver and copper exploration and mining companies, entertainment, media, advertising, technology, distribution/logistics, biotech/pharmaceutical, energy/oil drilling and financial services. Pursuant to the terms of its agreement with Barwicki Investor Relations, the Company will pay $3,000 per month. The agreement is a month-to-month contract and may be terminated at any time upon written notice.

Therma Bright is also pleased to announce that in the past two weeks, investors have exercised a total of 1,999,999 warrants and options to add $300,000 to the Company’s treasury. Included in this sum is 1,200,000 warrants ($175,000) exercised by directors and officers of the Company. These funds will be used for general working.

The Company also announces that pursuant to the Company’s 10% rolling stock option plan and in compliance with the policies of the TSX Venture Exchange, it has granted incentive stock options to consultants of the Company to purchase up to an aggregate of 450,000 common shares of the Company. These options are exercisable for a period of 5 years at a price of $0.22 per share.